Literature DB >> 26233933

Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes mellitus in the United Kingdom.

Kaan Tunceli1, Kristy Iglay2, Changgeng Zhao2, Kimberly G Brodovicz2, Larry Radican2.   

Abstract

To evaluate adherence to oral antihyperglycemic monotherapy, we conducted a retrospective cohort study of a UK clinical database. The mean proportion of days covered was 73.5%, and 60.1% of patients were adherent. Younger age and fewer concomitant medications were negatively associated with the likelihood of being adherent.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adherence; Drug therapy; Logistic regression analysis; Observational study; Oral antihyperglycemic agents; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 26233933     DOI: 10.1016/j.diabres.2015.05.031

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

1.  A cluster-randomized trial of the effectiveness of a triple-faceted intervention promoting adherence to primary care physician visits by diabetes patients.

Authors:  Mitsuhiko Noda; Yasuaki Hayashino; Katsuya Yamazaki; Hikari Suzuki; Atsushi Goto; Masayuki Kato; Kazuo Izumi; Masashi Kobayashi
Journal:  Sci Rep       Date:  2020-02-18       Impact factor: 4.379

2.  Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study.

Authors:  Yuexin Tang; Tracey Weiss; Jinan Liu; Swapnil Rajpathak; Kamlesh Khunti
Journal:  J Clin Transl Endocrinol       Date:  2020-04-16

3.  Adherence to Prescribed Acamprosate in Alcohol Dependence and 1-Year Morbidities and Mortality: Utilizing a Data Linkage Methodology.

Authors:  Serenella Tolomeo; Alex Baldacchino
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.